| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Apr 18, 2024 | Buy | $18.03 | 581,765 | 10,489,446 | 7,475,000 | Apr 22, 2024, 04:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Mar 30, 2024 | Option Exercise | $20.67 | 25,546 | 528,036 | 77,133 | Apr 02, 2024, 05:27 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | Feb 09, 2024 | Option Exercise | $28.80 | 14,943 | 430,358 | 165,013 | Feb 13, 2024, 05:40 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $28.80 | 5,083 | 146,390 | 44,787 | Feb 13, 2024, 05:39 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,656 | 105,293 | 46,617 | Feb 13, 2024, 05:38 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,192 | 91,930 | 45,065 | Feb 13, 2024, 05:38 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | President and CEO | Feb 09, 2024 | Option Exercise | $28.80 | 3,533 | 101,750 | 53,378 | Feb 13, 2024, 05:37 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Sale | $19.98 | 418 | 8,352 | 38,171 | Feb 05, 2024, 05:15 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Option Exercise | $19.36 | 98,650 | 1,909,586 | 85,830 | Jan 30, 2024, 04:53 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Sale | $16.10 | 52,034 | 837,768 | 63,979 | Jan 29, 2024, 05:54 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Sale | $19.01 | 1,200 | 22,809 | 37,105 | Jan 29, 2024, 05:51 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Option Exercise | $16.52 | 22,600 | 373,443 | 49,262 | Jan 26, 2024, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Sale | $16.54 | 1,200 | 19,848 | 38,562 | Jan 26, 2024, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Sale | $19.02 | 10,270 | 195,329 | 41,640 | Jan 25, 2024, 06:26 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Sale | $19.01 | 22,502 | 427,841 | 47,756 | Jan 25, 2024, 06:26 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | Jan 24, 2024 | Sale | $24.98 | 29,956 | 748,250 | 135,441 | Jan 25, 2024, 06:24 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | Jan 23, 2024 | Sale | $24.97 | 5,044 | 125,950 | 165,397 | Jan 25, 2024, 06:24 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Sale | $16.48 | 68,332 | 1,126,050 | 72,128 | Jan 24, 2024, 04:50 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Sale | $16.27 | 1,800 | 29,290 | 38,862 | Jan 24, 2024, 04:50 PM | |
| EYEP | EyePoint Pharmaceuticals, Inc. | Ocumension Therapeutics | Director | Jan 11, 2024 | Sale | $19.45 | 1,910,500 | 37,159,226 | 100,221 | Jan 16, 2024, 06:55 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Liu Ye | Director | Jan 11, 2024 | Sale | $19.45 | 1,910,500 | 37,159,226 | 100,221 | Jan 16, 2024, 06:01 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Jan 09, 2024 | Buy | $21.32 | 105,000 | 2,238,600 | 6,143,235 | Jan 11, 2024, 04:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Chen Bihua | 10% Owner | Jan 11, 2024 | Buy | $19.75 | 750,000 | 14,812,500 | 6,893,235 | Jan 11, 2024, 04:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Option Exercise | $12.19 | 45,826 | 558,821 | 59,418 | Jan 10, 2024, 04:53 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,487 | 91,535 | 36,505 | Jan 09, 2024, 09:28 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | Jan 06, 2024 | Option Exercise | $20.40 | 23,043 | 470,077 | 170,441 | Jan 09, 2024, 09:17 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Jan 06, 2024 | Option Exercise | $20.40 | 5,966 | 121,706 | 13,662 | Jan 09, 2024, 09:11 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,147 | 84,599 | 37,962 | Jan 09, 2024, 09:09 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | President and CEO | Jan 06, 2024 | Option Exercise | $20.40 | 6,528 | 133,171 | 43,486 | Jan 09, 2024, 09:07 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,911 | 100,184 | 35,308 | Jan 09, 2024, 09:04 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Option Exercise | $15.07 | 2,916 | 43,930 | 27,165 | Dec 15, 2023, 05:14 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Dec 08, 2023 | Buy | $17.00 | 588,235 | 9,999,995 | 6,038,235 | Dec 12, 2023, 04:52 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Sale | $17.35 | 91,000 | 1,578,690 | 50,343 | Dec 11, 2023, 04:15 PM | |
| EYEP | EyePoint Pharmaceuticals, Inc. | Ocumension Therapeutics | Director | Dec 05, 2023 | Sale | $19.91 | 733,758 | 14,609,122 | 2,276,963 | Dec 07, 2023, 09:21 PM | |
| EYEP | EyePoint Pharmaceuticals, Inc. | Ocumension Therapeutics | Director | Dec 06, 2023 | Sale | $18.41 | 266,242 | 4,901,515 | 2,010,721 | Dec 07, 2023, 09:21 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Liu Ye | Director | Dec 06, 2023 | Sale | $18.41 | 266,242 | 4,901,515 | 2,010,721 | Dec 07, 2023, 09:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Liu Ye | Director | Dec 05, 2023 | Sale | $19.91 | 733,758 | 14,609,122 | 2,276,963 | Dec 07, 2023, 09:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Option Exercise | $17.31 | 90,000 | 1,557,900 | 50,343 | Dec 06, 2023, 05:20 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Option Exercise | $16.07 | 61,250 | 983,981 | 56,332 | Dec 06, 2023, 05:19 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | Dec 04, 2023 | Sale | $20.76 | 20,000 | 415,200 | 170,559 | Dec 06, 2023, 05:18 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% Owner | Dec 04, 2023 | Buy | $21.82 | 1,919,057 | 41,874,150 | 5,450,000 | Dec 06, 2023, 04:39 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Sep 01, 2023 | Sale | $9.90 | 20,000 | 197,982 | 3,490,921 | Sep 06, 2023, 07:10 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Sep 01, 2023 | Sale | $9.90 | 20,000 | 197,982 | 3,490,921 | Sep 06, 2023, 05:14 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands IX, LLC | 10% Owner | Aug 30, 2023 | Sale | $10.92 | 60,976 | 666,147 | 3,589,743 | Sep 01, 2023, 04:51 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners-A, L.P. | 10% Owner | Aug 31, 2023 | Sale | $10.24 | 78,495 | 804,061 | 3,517,938 | Sep 01, 2023, 04:51 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Aug 28, 2023 | Sale | $11.71 | 60,858 | 712,653 | 3,738,246 | Aug 30, 2023, 05:46 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Aug 29, 2023 | Sale | $10.75 | 87,854 | 944,225 | 3,650,957 | Aug 30, 2023, 05:46 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners-A, L.P. | 10% Owner | Aug 24, 2023 | Sale | $11.17 | 139,280 | 1,556,155 | 3,935,940 | Aug 30, 2023, 05:32 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Aug 25, 2023 | Sale | $11.00 | 84,656 | 931,327 | 3,810,835 | Aug 30, 2023, 05:32 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Aug 24, 2023 | Sale | $14.62 | 139,280 | 2,036,093 | 3,883,760 | Aug 28, 2023, 06:32 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands IX, LLC | 10% Owner | Aug 25, 2023 | Sale | $11.00 | 84,656 | 931,479 | 3,853,760 | Aug 28, 2023, 06:32 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Aug 23, 2023 | Sale | $13.05 | 121,103 | 1,580,915 | 4,023,040 | Aug 24, 2023, 05:30 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Aug 22, 2023 | Sale | $14.62 | 46,778 | 683,834 | 4,144,143 | Aug 24, 2023, 05:30 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Liu Ye | Director | May 30, 2023 | Sale | $6.00 | 1 | 6 | 3,010,721 | May 31, 2023, 05:22 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2023 | Option Exercise | $4.17 | 3,744 | 15,612 | 27,429 | Feb 13, 2023, 05:07 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | President and COO | Feb 09, 2023 | Option Exercise | $4.17 | 4,148 | 17,297 | 30,943 | Feb 13, 2023, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2023 | Option Exercise | $4.17 | 2,956 | 12,327 | 26,606 | Feb 13, 2023, 05:02 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | Chief Operating Officer | Nov 01, 2022 | Option Exercise | $5.42 | 4,479 | 24,276 | 21,402 | Nov 03, 2022, 08:38 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Mar 14, 2022 | Buy | $12.21 | 1,000 | 12,210 | 1,000 | Mar 15, 2022, 04:21 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,130 | 11,243 | 15,599 | Mar 02, 2022, 06:22 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,294 | 12,875 | 18,651 | Mar 02, 2022, 06:21 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 9,602 | Feb 11, 2022, 04:41 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 15,840 | Feb 11, 2022, 04:39 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,473 | 14,921 | 12,624 | Feb 11, 2022, 04:39 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | President & CEO | Nov 15, 2021 | Sale | $20.15 | 10,000 | 201,480 | 103,546 | Nov 17, 2021, 05:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,423 | 15,383 | 11,592 | Mar 02, 2021, 07:26 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,702 | 18,399 | 7,380 | Mar 02, 2021, 07:25 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Sep 04, 2020 | Buy | $0.48 | 10,000 | 4,800 | 40,000 | Sep 09, 2020, 09:16 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Aug 24, 2020 | Buy | $0.61 | 10,000 | 6,112 | 30,000 | Aug 26, 2020, 09:21 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $0.76 | 14,060 | 10,643 | 26,990 | Jul 02, 2020, 06:15 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 30, 2020 | Option Exercise | $0.76 | 12,049 | 9,121 | 89,144 | Jul 02, 2020, 06:14 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2020 | Option Exercise | $0.79 | 2,936 | 2,317 | 60,143 | Jun 30, 2020, 07:52 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2020 | Option Exercise | $0.83 | 4,168 | 3,441 | 53,079 | Jun 16, 2020, 05:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Mar 12, 2020 | Buy | $0.96 | 10,000 | 9,600 | 20,000 | Mar 13, 2020, 08:41 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | President & CEO | Mar 10, 2020 | Buy | $1.06 | 98,000 | 104,027 | 574,800 | Mar 11, 2020, 08:40 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | Nov 15, 2019 | Buy | $1.43 | 10,000 | 14,290 | 10,000 | Nov 18, 2019, 08:42 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | President & CEO | Oct 12, 2019 | Option Exercise | $2.11 | 10,745 | 22,618 | 314,455 | Oct 15, 2019, 06:04 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2019 | Option Exercise | $2.11 | 2,450 | 5,157 | 43,047 | Oct 15, 2019, 06:03 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Mazzo David J | Director | Oct 09, 2019 | Option Exercise | $1.95 | 33,333 | 64,999 | 200,083 | Oct 11, 2019, 06:13 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Jun 27, 2019 | Option Exercise | $1.65 | 1,961 | 3,236 | 90,044 | Jun 28, 2019, 05:04 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2019 | Option Exercise | $1.65 | 2,940 | 4,851 | 45,497 | Jun 28, 2019, 05:04 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Jun 14, 2019 | Option Exercise | $1.53 | 2,394 | 3,663 | 85,338 | Jun 17, 2019, 05:41 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2019 | Option Exercise | $1.53 | 4,175 | 6,388 | 38,437 | Jun 17, 2019, 05:40 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Landis John B. | Director | May 13, 2019 | Buy | $1.74 | 40,000 | 69,600 | 40,000 | May 15, 2019, 04:55 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | Director | Apr 12, 2019 | Option Exercise | $1.77 | 20,000 | 35,400 | 37,500 | Apr 16, 2019, 08:16 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | Director | Apr 01, 2019 | Buy | $1.89 | 5,000 | 9,450 | 17,500 | Apr 03, 2019, 08:25 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Apr 01, 2019 | Option Exercise | $1.81 | 5,000 | 9,050 | 79,452 | Apr 02, 2019, 08:24 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | President & CEO | Mar 29, 2019 | Buy | $1.76 | 28,500 | 50,246 | 240,200 | Apr 01, 2019, 08:23 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Mazzo David J | Director | Mar 29, 2019 | Option Exercise | $1.77 | 20,000 | 35,400 | 158,000 | Apr 01, 2019, 08:21 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Godshall Douglas Evan | Director | Mar 29, 2019 | Buy | $1.75 | 17,000 | 29,784 | 29,500 | Apr 01, 2019, 08:20 AM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Mar 19, 2019 | Option Exercise | $2.47 | 1,188 | 2,934 | 28,412 | Mar 21, 2019, 05:24 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Mar 19, 2019 | Option Exercise | $2.47 | 1,735 | 4,285 | 74,452 | Mar 21, 2019, 05:22 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Dec 22, 2018 | Option Exercise | $1.65 | 18,522 | 30,561 | 76,187 | Dec 26, 2018, 04:06 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | ROGERS MICHAEL W | Director | Nov 15, 2018 | Option Exercise | $1.13 | 100,000 | 113,000 | 112,500 | Nov 16, 2018, 04:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Oct 12, 2018 | Option Exercise | $3.23 | 2,945 | 9,512 | 31,817 | Oct 16, 2018, 04:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2018 | Option Exercise | $3.23 | 2,455 | 7,930 | 29,600 | Oct 16, 2018, 04:00 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands IX, LLC | 10% Owner | Jun 25, 2018 | Buy | $1.26 | 16,211,822 | 20,507,955 | 25,470,390 | Jul 03, 2018, 06:23 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Essex Woodlands IX, LLC | 10% Owner | Jun 25, 2018 | Buy | $1.26 | 652,244 | 825,089 | 25,470,390 | Jul 03, 2018, 06:23 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Ross Leonard S | See Remarks | Jun 27, 2018 | Option Exercise | $1.86 | 1,904 | 3,541 | 14,762 | Jun 29, 2018, 04:01 PM | |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2018 | Option Exercise | $1.86 | 2,945 | 5,478 | 15,388 | Jun 29, 2018, 04:00 PM |
Menu